Trump Scores Another Win Against New York's Corrupt 'Justice' System
Trump Has Decided Who He Won't Pick for FBI Director
Here's Pam Bondi's Stance on Illegal Immigration and Cartel Traffickers
CNN Legal Analyst Just Shredded Dems' Top Narrative Against Trump's AG Pick
Scott Presler to PA Dems Who Tried to Steal the Election: We're Coming...
Here's What Caused a Woman to Chop Up Her Father on Election Night
The Trump Counter-Revolution Is a Return to Sanity
One of Trump’s Biggest Allies Says He’s Never Getting Into Politics Again
MTG to Chair a New DOGE Subcommittee
Tom Cotton Issues 'Friendly Reminder' to ICC After Arrest Warrants for Netanyahu, Gallant
'Obstructionist Transition': Biden Administration Is 'Loosening Immigration Policies' on t...
New Legislation Puts the Department of Education on the Chopping Block
DOJ Calls for Google to Sell the Chrome Browser
Georgia Conducted a Hand Count Audit of Its Election Results. Guess What it...
Top Pollster Calls on Joe Biden to Resign
Tipsheet

CDC Vaccine Advisers Schedule Meetings to Discuss Boosters and Vaccines for Children

AP Photo/Matt Rourke

Vaccine advisers for the United States Centers for Disease Control and Prevention (CDC) have scheduled two upcoming meetings to discuss COVID-19 vaccine booster shots and vaccines for children ages 5-11, CNN reported this week.

Advertisement

According to the report, the CDC’s independent Advisory Committee on Immunization Practices (ACIP) will meet on Oct. 20 and 21 to discuss booster shots, specifically, Johnson & Johnson and Moderna. Currently, Johnson & Johnson is seeking FDA approval for their booster and Moderna works on developing a booster, possibly, a combination vaccine against the seasonal flu and Wuhan coronavirus booster. Next month, the ACIP will reportedly meet on Nov. 2 and 3 to discuss pediatric COVID-19 vaccination. 

On a different note, the Food and Drug Administration (FDA) has reportedly scheduled two meetings pertaining to boosters on Oct. 14 and 15. On Oct. 26, FDA advisers will convene to discuss Pfizer’s application for vaccines for children ages 5-11. We reported this week that last month the company had announced that there were "positive topline results" for vaccine trials in this age demographic.

Advertisement

As of right now, Pfizer’s booster shot has approval from the FDA for individuals age 65 and over and for individuals who are high-risk at contracting severe COVID-19. 

This week, we covered how a group of COVID-19 experts reportedly urged the Biden administration to scale back its agenda regarding booster shots. The experts on an off-the-record call with federal health officials reportedly said that current U.S. data on vaccine performance does not justify the widespread use of booster shots to combat breakthrough COVID-19 cases and slow the spread. 

While President Biden continues to push for boosters, we will see if the CDC and FDA will follow suit.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement